欢迎登录材料期刊网

材料期刊网

高级检索

用RP-HPLC分离测定了麻黄及其制剂中的麻黄类生物碱及川芎嗪。采用色谱柱Nova-Pak C18(150 mm×3.9 mm i.d.),二极管阵列检测器(DAD)。测定麻黄类生物碱时,以甲醇-0.02 mol/L KH2PO4-乙酸-三乙胺(体积比为4∶96∶0.2∶0.01)为流动相,在210 nm波长下检测;测定川芎嗪时,以甲醇-水-乙酸(体积比为35∶65∶0.5) 为流动相, 在290 nm波长下检测。分别测定了麻黄原药材、中成药(小儿清肺丸、鹭鸶咳丸)中麻黄碱、伪麻黄碱、去甲基麻黄碱、去甲基伪麻黄碱和川芎嗪的含量,检出限分别为0.4 mg/L,0.1 mg/L,0.03 mg/L,0.02 mg/L,0.03 mg/L。该法准确、灵敏、快速。

A sensitive and reliable high performance liquid chromatographic method(HPLC) has been developed for the first time for the simultaneous determination of the active ingredients of ephedrine alkaloids and 2,3,5,6-tetramethyl pyrazine (TMP) in Ephedra herba crude drug and two Chinese traditional medicines (Xiao-er qingfeiwan and Lu-si kewan). The HPLC assay was performed on a reversed phase C18 column (Nova-Pak C18, 3.9 mm i.d.×150 mm) by using methanol-0.02 mol/L KH2PO4-acetic acid-triethyl amine (4∶96∶0.2∶0.01, V/V) as mobile phase for the ephedrine alkaloids analysis and methanol-H\-2O-acetic acid (35∶65∶0.5,V/V) as mobile phase for TMP analysis. Regression equations revealed the linear relationships (correlation coefficients: 0.991-0.998) between the peak area of each constituent (E, PE, NE, NPE, TMP) and its concentration. The detection limits for E, PE, NE, NPE and TMP were 0.4 mg/L, 0.1 mg/L, 0.03 mg/L, 0.02 mg/L and 0.03 mg/L, respectively, and the recoveries ranged between 92%-103%. The contents of E, PE, NE, NPE, TMP in Ephedra herba, traditional medicine Xiao-er qingfeiwan and Lu-si kewan were determined respectively. The relative standard deviations (RSD) of the contents ranged between 1.1%-3%.

参考文献

[1] HUANG Tai-kang. The handbook of common Chinese medicine and pharmacology. Beijing:Chinese Medicine Science and Technology Press,1994. 1 624-1 631黄泰康. 常用中药成分与药理手册. 北京:中国医药科技出版社,1994. 1 624-1 631
[2] Iwanami N, Ootsuka K, Kubo H. Bulletin Pharm,1985,20(3):149-153 岩浪登, 大冢恭男,久保博昭. 药学通报,1985,20(3):149-153
[3] Sagara K, Oshima T, Misaki T. Chem Pharm Bull, 1983, 31(7):2 359-2 365
[4] SHAO Gang, WU Fang, WANG De-sheng, et al. Acta Pharmaceutica Sinica ,1995,30(5):384-389邵刚,吴芳,王德胜,等.药学学报,1995,30(5):384-389
[5] YANG Li-li,YUAN Yi-sheng, TONG Yong-ling, et al. Acta Pharmaceutica Sinica, 1994, 29(9): 697-701杨丽莉,袁倚盛,佟永岭,等. 药学学报, 1994, 29(9):697-701
[6] JIA Yuan-yin,ZHANG Ling,LIU Jian-hua, et al. Chinese Pharmaceutical Journal,1989, 24(7):402-404贾元印,张玲,刘建华,等. 中国药学杂志,1989, 24(7):402-404
[7] JIN Xiao,WANG Shan,ZHANG Chang-jiu. Acta Pharmaceutica Sinica,1994, 29(5):375-379金晓,王杉,张长久. 药学学报,1994, 29(5):375-379
上一张 下一张
上一张 下一张
计量
  • 下载量()
  • 访问量()
文章评分
  • 您的评分:
  • 1
    0%
  • 2
    0%
  • 3
    0%
  • 4
    0%
  • 5
    0%